TownSquare Capital’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-24,700
Closed -$706K 742
2021
Q2
$706K Sell
24,700
-2,515
-9% -$49.4K 0.02% 370
2021
Q1
$449K Buy
+27,215
New +$620K 0.02% 417

TownSquare Capital's TBIO Position: Q3 2021 in Review

TownSquare Capital sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 24,700 shares — an estimated $706K sold.

TownSquare Capital first reported a position in TBIO in Q1 2021 and held it in 2 quarters. The position peaked at $706K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • TownSquare Capital reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • TownSquare Capital sold 24,700 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $706K.
  • TownSquare Capital first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • TownSquare Capital's Translate Bio, Inc. Common Stock position peaked at $706K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on TownSquare Capital's 13F filing for Q3 2021, filed 15 Nov 2021.